epidemiologyЭпидемиология и ВакцинопрофилактикаEpidemiology and Vaccinal Prevention2073-30462619-0494«Numicom» LLC10.31631/2073-3046-2026-26-2-124-130epidemiology-2410Research ArticleОБЗОРREVIEWВирусный гепатит С у детейViral Hepatitis C in Childrenhttps://orcid.org/0000-0003-4228-9044АкимкинВ. Г.AkimkinV. G.

Василий Геннадьевич Акимкин – академик РАН, д. м. н., профессор, директор 

Москва

Vasily G. Akimkin – Academician of the Russian Academy of Sciences, Dr. Sci. (Med.), Professor, Director 

Moscow

https://orcid.org/0000-0002-6539-4878ПонежеваЖ. Б.PonezhevaZh. B.

Жанна Бетовна Понежева – д. м. н., заведующая клиническим отделом инфекционной патологии 

Москва

Zhanna B. Ponezheva – Cand. Sci. (Med.), Head of the Department of Clinical Department of Infectious Pathology 

Moscow

https://orcid.org/0000-0002-9682-2230ОмароваЖ. Г.OmarovaH. G.

Хадижат Гаджиевна Омарова – к. м. н., заведующая отделом клинических исследований 

Москва

Khadizhat G. Omarova – Cand. Sci. (Med.), Head of the Department of Clinical Research 

Moscow

https://orcid.org/0000-0001-6842-908XТагироваЗ. Г.TagirovaZ. G.

Зарема Гаджимирзоевна Тагирова – д. м. н.

Москва

Zarema G. Tagirova – Dr. Sci. (Med.), Head of the Department of Clinical Research

Moscow

https://orcid.org/0000-0002-1322-0155УглеваС. В.UglevaS. V.

Углева Светлана Викторовна, д. м. н., доцент

Москва

Ugleva Svetlana V., Dr. Sci. (Med.), Associate Professor

Moscow

uglevas@bk.ruhttps://orcid.org/0000-0003-4930-5756ШабалинаС. В.ShabalinaS. V.

Светлана Васильевна Шабалина – д. м. н., профессор, ведущий научный сотрудник клинического отдела инфекционной патологии 

Москва

Svetlana V. Shabalina – Dr. Sci. (Med.), Professor, Leading Researcher of the Clinical Department of Infectious Pathology 

Moscow

ЦНИИ Эпидемиологии РоспотребнадзораРоссияCentral Research Institute of Epidemiology of RospotrebnadzorRussian FederationИнститут дезинфектологии ФБУН «ФНЦГ им. Ф. Ф. Эрисмана» РоспотребнадзораРоссияInstitute of Disinfection of the FNTSG named after F.F. Erisman of RospotrebnadzorRussian Federation202610052026252124130Copyright © Акимкин В.Г., Понежева Ж.Б., Омарова Ж.Г., Тагирова З.Г., Углева С.В., Шабалина С.В., 20262026Акимкин В.Г., Понежева Ж.Б., Омарова Ж.Г., Тагирова З.Г., Углева С.В., Шабалина С.В.Akimkin V.G., Ponezheva Z.B., Omarova H.G., Tagirova Z.G., Ugleva S.V., Shabalina S.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.epidemvac.ru/jour/article/view/2410Актуальность

Актуальность. Несмотря на достаточно полное изучение многих аспектов гепатита С (ГС) – эпидемиологии, диагностики, клиники, иммунологии и др., – инфекция остается во многом нерешенной проблемой из-за высокой распространенности, трудности диагностики острой стадии болезни, частых неблагополучных исходов.

Материал

Материал. В обзоре использовались научные информационные базы данных (eLIBRARY.RU, Киберленинка, Федеральная электронная медицинская библиотека, PubMed). Глубина изучения – 5 лет, с ретроспективой 20 лет.

Заключение

Заключение. Проблема ГС в настоящее время является предметом широкого внимания и глубокого изучения во многих странах. В частности, в РФ, в рамках внедрения Национальной стратегии элиминации гепатита С, был разработан и принят план, направленный на резкое снижение заболеваемости этой инфекцией к 2030 г.

Relevance

Relevance. In the world, the study of many aspects of hepatitis C (HC) – epidemiology, diagnostics, clinic, immunology, etc. – the infection remains largely an unresolved problem of public health due to the high prevalence, the difficulty of diagnosing the acute stage of the disease, frequent unfavorable outcomes.

Aims

Aims. Analysis of scientific publications concerning the problem of hepatitis C in children.

Material

Material. The review used scientific information databases (eLIBRARY.RU, Cyberleninka, Federal electronic medical library, PubMed). The depth of study is 5 years, with a 20-year retrospective.

Conclusion

Conclusion. The problem of HCV is currently the subject of widespread attention and in-depth study in many countries. In particular, in the Russian Federation, as part of the implementation of the National Strategy for the Elimination of Hepatitis C, a plan has been developed and adopted aimed at a sharp decrease in the incidence of this infection by 2030.

детихронический гепатит Сперинатальное инфицированиеспонтанный клиренсchildrenchronic hepatitis Cperinatal infectionspontaneous clearanceReferencesEASL recommendations on treatment of hepatitis C: Final update of the series. J Hepatol. 2020 Nov;73(5):1170–1218. doi: 10.1016/j.jhep.2020.08.018.EASL recommendations on treatment of hepatitis C: Final update of the series. J Hepatol. 2020 Nov;73(5):1170–1218. doi: 10.1016/j.jhep.2020.08.018.О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2024 году: Государственный доклад. М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2025.On the State of Sanitary and Epidemiological Well-Being of the Population in the Russian Federation in 2024: State Report. Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Welfare, 2025. (In Russ.).Hepatitis C. Key facts: WHO, 2020. Доступно на https://www.who.int/news-room/fact-sheets/detail/hepatitis-cHepatitis C. Key facts: WHO, 2020. Доступно на https://www.who.int/news-room/fact-sheets/detail/hepatitis-cГалова Е. А. Многолетняя динамика заболеваемости хроническим вирусным гепатитом С детей в Российской Федерации. Здравоохранение Российской Федерации. 2019; 63(6):292–299. DOI: http://dx.doi.org/10.18821/0044-197X-2019-63-6-292-299Galova E. A. Long-term dynamics of the incidence of chronic viral hepatitis C in children in the Russian Federation. Health Care of the Russian Federation. 2019; 63(6):292– 299. (In Russ.). DOI: http://dx.doi.org/10.18821/0044-197X-2019-63-6-292-299World Health Organization. Guidelines for the screening, care, and treatment of persons with chronic hepatitis C infection, 2019. Доступно на: https://apps.who.int/iris/bitstream/handle/10665/111747/9789241548755_eng.pdf?sequence=1World Health Organization. Guidelines for the screening, care, and treatment of persons with chronic hepatitis C infection, 2019. Available at: https://apps.who.int/iris/bitstream/handle/10665/111747/9789241548755_eng.pdf?sequence=1Понежева Ж. Б., Акимкин В. Г., Маннанова И. В. и др. Взаимосвязь иммунологических показателей с выраженностью фиброза печени у больных хроническим гепатитом С. Эпидемиология и инфекционные болезни. Актуальные вопросы. 2023; 13(1):78– 82. https://dx.doi.org/10.18565/epidem.2023.13.1.78-82Ponezheva Zh. B., Akimkin V. G., Mannanova I. V., et al. Relationship of immunological parameters with the severity of liver fibrosis in patients with chronic hepatitis C. Epi- demiology and Infectious Diseases. Current Issues. 2023; 13(1):78–82. (In Russ.). https://dx.doi.org/10.18565/epidem.2023.13.1.78-82Статистика гепатита С за 2020 год: знают ли пациенты о своем диагнозе? 2020. Доступно на: https://gepatit-abc.ru/statistika-gepatita-s-za-2020-god-znayut-li-pacienty-o-svoem-diagnoze/2020 statistics on hepatitis C: do patients know about their diagnosis? 2020. (In Russ.). Available at: https://gepatit-abc.ru/statistika-gepatita-s-za-2020-god-znayut-lipacienty-o-svoem-diagnoze/Бохонов М. С., Галицина Л. Е., Ситников И. Г. и др. Клинические особенности хронического гепатита С у детей. Детские инфекции. 2023; 22(2):23–27. doi.org/10.22627/2072-8107-2023-22-2-23-27Bokhonov M. S., Galitsina L. E., Sitnikov I. G., et al. Clinical Features of Chronic Hepatitis C in Children. Children’s Infections. 2023; 22(2):23–27. (In Russ.).doi.org/10.22627/2072-8107-2023-22-2-23-27Давидович Н. В., Соловьева Н. В. Иммунный ответ при вирусном гепатите С: ведущая роль натуральных киллеров. Вестник Северного (Арктического) федерального университета. 2015; 4: 68–78.Davidovich N. V., Solovyova N. V. Immune response in viral hepatitis C: the leading role of natural killers. Bulletin of the Northern (Arctic) Federal University. 2015; 4: 68–78. (In Russ.).Vajro P., Veropalumbo C., Maddaluno S., et al. Treatment of children with chronic viral hepatitis: what is available and what is in store. World J. Pediatr. 2013; 9 (3): 212–220Vajro P., Veropalumbo C., Maddaluno S., et al. Treatment of children with chronic viral hepatitis: what is available and what is in store. World J. Pediatr. 2013; 9 (3): 212–220Khamis HH, Farghaly AG, Shatat HZ, El-Ghitany EM. Prevalence of hepatitis C virus infection among pregnant women in a rural district in Egypt. Tropical Doctor. 2016; 46 (1): 21–27. doi: 10.1177/0049475514561330.Khamis HH, Farghaly AG, Shatat HZ, El-Ghitany EM. Prevalence of hepatitis C virus infection among pregnant women in a rural district in Egypt. Tropical Doctor. 2016; 46 (1): 21–27. doi: 10.1177/0049475514561330.Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update. Gastroenterology, Hepatology, and Nutrition Position Paper. J Pediatr Gastroenterol Nutr. 2020 Sep; 71(3):407–417. doi: 10.1097/MPG.00Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update. Gastroenterology, Hepatology, and Nutrition Position Paper. J Pediatr Gastroenterol Nutr. 2020 Sep; 71(3):407–417. doi: 10.1097/MPG.00Kim H.S., El-Serag H.B. The epidemiology of hepatocellular carcinoma in the USA. Curr. Gastroenterol. Rep. 2019; 21(4):17–22. Doi: https://doi.org/10.1007/s11894-019-0681-xKim H.S., El-Serag H.B. The epidemiology of hepatocellular carcinoma in the USA. Curr. Gastroenterol. Rep. 2019; 21(4):17–22. Doi: https://doi.org/10.1007/s11894-019-0681-xВенцловайте Н. Д., Горячева Л. Г., Грешнякова В. А. и др. Вирусный гепатит С у детей: ретроспективный анализ и перспективы на будущее. Клиническая инфектология и паразитология. 2021;10(2):208–218.Ventslovate N. D., Goryacheva L. G., Greshnyakova V. A., et al. Viral hepatitis C in children: retrospective analysis and future prospects. Clinical Infectology and Parasitology. 2021;10(2):208–218. (In Russ.).Лейбман Е. А., Николаева Л. И., Самохвалов Е. И. и др. Особенности течения гепатита С у детей в зависимости от субтипа вируса. Эпидемиология и Вакцинопрофилактика. 2015;1:49–55.Leibman E. A., Nikolaeva L. I., Samokhvalov E. I., et al. Features of the course of hepatitis C in children depending on the virus subtype. Epidemiology and Vaccinal Prevention. 2015;1:49–55. (In Russ.).Gower E., Estes C.C., Hindman S., et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol. 2014. 61: S45–S47.Gower E., Estes C.C., Hindman S., et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol. 2014. 61: S45–S47.Волынец Г. В., Потапов А. С., Скворцова Т. А. Хронический вирусный гепатит С у детей: проблемы и перспективы. Вестник РАМН. 2014; 11–12: 46–53.Volynets G. V., Potapov A. S., Skvortsova T. A. Chronic Viral Hepatitis C in Children: Problems and Prospects. Bulletin of the Russian Academy of Medical Sciences. 2014; 11–12: 46–53. (In Russ.).Эсауленко Е. В., Ветров Т. А., Дунаев Н. В. и др. Распространение генотипов вируса гепатита С в Санкт-Петербурге. Вирусные гепатиты: перспектива и развитие. 2014;1:14–16.Esaulenko E. V., Vetrov T. A., Dunaev N. V., et al. Distribution of hepatitis C virus genotypes in St. Petersburg. Viral hepatitis: perspective and development. 2014;1:14–16. (In Russ.).Николаева Л. И., Тойчуев Р. М., Лейбман Е. А. и др. Факторы, влияющие на течение хронического гепатита С у детей. Эпидемиология и вакцинопрофилактика. 2013; 6: 37–44.Nikolaeva L. I., Toychuev R. M., Leibman E. A., et al. Factors Affecting the Course of Chronic Hepatitis C in Children. Epidemiology and Vaccinal Prevention. 2013; 6: 37–44. (In Russ.).Акимкин В. Г., Понежева Ж. Б., Омарова Х. Г. и др. Вирусный гепатит С у беременных и новорожденных. Инфекционные болезни, 2023, 21(1)114–118.Akimkin V. G., Ponezheva Zh. B., Omarova Kh. G., et al. Viral hepatitis C in pregnant women and newborns. Infectious Diseases, 2023, 21(1)114–118. (In Russ.).Горячева Л. Г., Грешнякова В. А., Рогозина Н. В. и др. Перинатальный вирусный гепатит С и возможности его лечения. Эпидемиология и инфекционные болезни. 2014; 18 (2): 4–8.Goryacheva L. G., Greshnyakova V. A., Rogozina N. V., et al. Perinatal Viral Hepatitis C and Its Treatment Options. Epidemiology and Infectious Diseases. 2014; 18 (2): 4–8. (In Russ.).Andes A, Ellenberg K, Vakos A, et al. Hepatitis C Virus in Pregnancy: A Systematic Review of the Literature. Am J Perinatol. 2021 Aug;38(S 01):e1–e13. DOI: 10.1055/s-0040-1709672Andes A, Ellenberg K, Vakos A, et al. Hepatitis C Virus in Pregnancy: A Systematic Review of the Literature. Am J Perinatol. 2021 Aug;38(S 01):e1–e13. DOI: 10.1055/s-0040-1709672McCormick CA, Domegan L, Carty PG, et al. Routine screening for hepatitis C in pregnancy is cost-effective in a large urban population in Ireland: a retrospective study. BJOG. 2022 Jan;129(2):322–327. DOI: 10.1111/1471-0528.16984McCormick CA, Domegan L, Carty PG, et al. Routine screening for hepatitis C in pregnancy is cost-effective in a large urban population in Ireland: a retrospective study. BJOG. 2022 Jan;129(2):322–327. DOI: 10.1111/1471-0528.16984Aboubakar M, Kpossou AR, Glago BRGH, et al. Prévalence et facteurs associés au portage des anticorps anti-VHC chez des femmes enceintes à Cotonou [Prevention and factors associated with anti-ВГС carriage in pregnant women living in Cotonou]. Pan Afr Med J. 2020 Jul 14;36:182. DOI: 10.11604/pamj.2020.36.182.23122 [ In French]Aboubakar M, Kpossou AR, Glago BRGH, et al. Prévalence et facteurs associés au portage des anticorps anti-VHC chez des femmes enceintes à Cotonou [Prevention and factors associated with anti-ВГС carriage in pregnant women living in Cotonou]. Pan Afr Med J. 2020 Jul 14;36:182. DOI: 10.11604/pamj.2020.36.182.23122 [ In French]Walker KF, Bugg G, Macpherson M, et al. Induction of labour versus expectant management for nulliparous women over 35 years of age: a multi-centre prospective, ran- domised controlled trial. BMC Pregnancy Childbirth. 2012 Dec 11;12:145. DOI: 10.1186/1471-2393-12-145Walker KF, Bugg G, Macpherson M, et al. Induction of labour versus expectant management for nulliparous women over 35 years of age: a multi-centre prospective, ran- domised controlled trial. BMC Pregnancy Childbirth. 2012 Dec 11;12:145. DOI: 10.1186/1471-2393-12-145Постановление Главного государственного санитарного врача РФ от 28.01.2021 N 4 (ред. от 25.05.2022) Об утверждении санитарных правил и норм СанПиН 3.3686-21 «Санитарно-эпидемиологические требования по профилактике инфекционных болезней».Resolution No. 4 of the Chief State Sanitary Inspector of the Russian Federation dated January 28, 2021 (as amended on May 25, 2022), approving the sanitary rules and regulations SanPiN 3.3686-21 «Sanitary and Epidemiological Requirements for the Prevention of Infectious Diseases». (In Russ.).Jhaveri R, Hashem M, El-Kamary SS, et al. Hepatitis C Virus (HCV) Vertical Transmission in 12-Month-Old Infants Born to HCV-Infected Women and Assessment of Maternal Risk Factors. Open Forum Infectious Diseases. 2015; 2 (2): ofv089. doi: 10.1093/ofid/ofv089.89Jhaveri R, Hashem M, El-Kamary SS, et al. Hepatitis C Virus (HCV) Vertical Transmission in 12-Month-Old Infants Born to HCV-Infected Women and Assessment of Maternal Risk Factors. Open Forum Infectious Diseases. 2015; 2 (2): ofv089. doi: 10.1093/ofid/ofv089.89Kushner T, Terrault NA. Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care. Hepatol Commun. 2018 Nov 30;3(1):20–28. DOI: 10.1002/hep4.1282Kushner T, Terrault NA. Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care. Hepatol Commun. 2018 Nov 30;3(1):20–28. DOI: 10.1002/hep4.1282Aebi-Popp K, Duppenthaler A, Rauch A, et al. Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland. Journal of Virus Eradication. 2016; 2 (1): 52–54.Aebi-Popp K, Duppenthaler A, Rauch A, et al. Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland. Journal of Virus Eradication. 2016; 2 (1): 52–54.Elrazek A, Amer M, El-Hawary B, et al. Prediction of HCV vertical transmission: what factors should be optimized using data mining computational analysis. Liver interna- tional: official journal of the International Association for the Study of the Liver. 2017; 37 (4): 529–533. doi: 10.1111/liv.13146.Elrazek A, Amer M, El-Hawary B, et al. Prediction of HCV vertical transmission: what factors should be optimized using data mining computational analysis. Liver interna- tional: official journal of the International Association for the Study of the Liver. 2017; 37 (4): 529–533. doi: 10.1111/liv.13146.Ades, AE ∙ Gordon, F ∙ Scott, K, et al. Overall vertical transmission of hepatitis C virus, transmission net of clearance, and timing of transmission. Clin Infect Dis. 2023; 76:905– 912Ades, AE ∙ Gordon, F ∙ Scott, K, et al. Overall vertical transmission of hepatitis C virus, transmission net of clearance, and timing of transmission. Clin Infect Dis. 2023; 76:905 912Mavilia MG, Wu GY. Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis. Journal of Clinical and Translational Hepatology. 2017; 5 (2): 119–129. doi: 10.14218/JCTH.2016.00067Mavilia MG, Wu GY. Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis. Journal of Clinical and Translational Hepatology. 2017; 5 (2): 119–129. doi: 10.14218/JCTH.2016.00067Белопольская М.А. Вирусный гепатит С и беременность. Вестник Российского университета дружбы народов. Серия: Медицина. 2011; 5: 111–117.Belopolskaya M.A. Viral hepatitis C and pregnancy. Bulletin of the Peoples’ Friendship University of Russia. Series: Medicine. 2011; 5: 111–117. (In Russ.).Cottrell EB, Chou R, Wasson N, et al. Reducing Risk for Mother-to-Infant Transmission of Hepatitis C Virus: A Systematic Review for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2013; 158 (2): 109–113Cottrell EB, Chou R, Wasson N, et al. Reducing Risk for Mother-to-Infant Transmission of Hepatitis C Virus: A Systematic Review for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2013; 158 (2): 109–113Хаматова А. А., Мазус А. И. и др. Распространенность ко-инфекции ВИЧ/ВГС у беременных. Факторы риска перинатальной передачи ВИЧ/ВГС. Инфекционные болезни. 2022;20(1):91–98.Khamatova A. A., Mazus A. I., et al. Prevalence of HIV/HCV co-infection in pregnant women. Risk factors for perinatal transmission of HIV/HCV. Infectious Diseases. 2022;20(1):91–98. (In Russ.).Якимова А. В., Мухамедшина В. Р., Кучеренко С. Г. Вирусный гепатит С при беременности: распространенность, влияние на перинатальные исходы, тактика ведения пациентов (обзор литературы). Consilium Medicum. 2022;24(7):477–480. DOI: 10.26442/20751753.2022.7.201799Yakimova A. V., Mukhamedshina V. R., Kucherenko S. G. Viral hepatitis C in pregnancy: prevalence, impact on perinatal outcomes, and management tactics (literature review). Consilium Medicum. 2022;24(7):477–480. DOI: 10.26442/20751753.2022.7.201799Mast EE, Hwang LYu, Dexter SY, et al. Risk Factors for Perinatal Transmission of Hepatitis C Virus (HCV) and the Natural History of HCV Infection Acquired in Infancy. The Journal of Infectious Diseases 2005; 192:1880–9Mast EE, Hwang LYu, Dexter SY, et al. Risk Factors for Perinatal Transmission of Hepatitis C Virus (HCV) and the Natural History of HCV Infection Acquired in Infancy. The Journal of Infectious Diseases 2005; 192:1880–9Epstein RL, Sabharwal V, Wachman EM, et al. Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care. J. Pediatr. 2018; 203: 34–40.e1. doi: 10.1016/j.jpeds.2018.07.006.Epstein RL, Sabharwal V, Wachman EM, et al. Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care. J. Pediatr. 2018; 203: 34–40.e1. doi: 10.1016/j.jpeds.2018.07.006.Pfaender S, Heyden J, Friesland M, et al. Inactivation of hepatitis C virus infectivity by human breast milk. The Journal of Infectious Diseases. 2013; 208 (12): 1943–1952 doi: 10.1093/infdis/jit519.Pfaender S, Heyden J, Friesland M, et al. Inactivation of hepatitis C virus infectivity by human breast milk. The Journal of Infectious Diseases. 2013; 208 (12): 1943–1952 doi: 10.1093/infdis/jit519.Mok J, Pembrey L, Tovo PA, Newell ML. European Paediatric Hepatitis C Virus Network. When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal Ed. 2005 Mar;90(2):F156–60. DOI: 10.1136/adc.2004.059436Mok J, Pembrey L, Tovo PA, Newell ML. European Paediatric Hepatitis C Virus Network. When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal Ed. 2005 Mar;90(2):F156–60. DOI: 10.1136/adc.2004.059436Panagiotakopoulos, L, ∙ Sandul, AL, ∙ Conners, EE , et al. CDC recommendations for hepatitis C testing among perinatally exposed infants and children – United States, 2023. MMWR Recomm Rep. 2023; 72:1–21Panagiotakopoulos, L, ∙ Sandul, AL, ∙ Conners, EE , et al. CDC recommendations for hepatitis C testing among perinatally exposed infants and children – United States, 2023. MMWR Recomm Rep. 2023; 72:1–21Galoppo M., Galoppo C. Management of hepatitis C virus infection in childhood. Ann. Hepatol. 2010; 9 (1): 98–102.14.Galoppo M., Galoppo C. Management of hepatitis C virus infection in childhood. Ann. Hepatol. 2010; 9 (1): 98–102.14.Mohan N., González-Peralta R.P., Fujisawa T., et al.Chronic hepatitis C virus infection in children. J. Pediatr. Gastroenterol. Nutr. 2010; 50 (2): 123–131.Mohan N., González-Peralta R.P., Fujisawa T., et al.Chronic hepatitis C virus infection in children. J. Pediatr. Gastroenterol. Nutr. 2010; 50 (2): 123–131.Кузьмин В. Н. Вирусный гепатит С у беременных: современная проблема акушерства. Лечащий врач. 2012; 3: 27–32.Kuzmin V. N. Viral hepatitis C in pregnant women: a modern problem of obstetrics. Lechashchiy vrach. 2012; 3: 27–32. (In Russ.).Jhaveri R, Hashem M, El-Kamary SS, et al. Hepatitis C Virus Vertical Transmission in 12-Month Old Infants Born to HCV-Infected Women and Assessment of Maternal Risk Factors. Open Forum Infect Dis. 2015;2(2):ofv089.Jhaveri R, Hashem M, El-Kamary SS, et al. Hepatitis C Virus Vertical Transmission in 12-Month Old Infants Born to HCV-Infected Women and Assessment of Maternal Risk Factors. Open Forum Infect Dis. 2015;2(2):ofv089.Kerkar N, Hartjes K. Hepatitis C Virus – Pediatric and Adult Perspectives in the Current Decade. Pathogens 2025, 14(1), 11. https://doi.org/10.3390/pathogens14010011Kerkar N, Hartjes K. Hepatitis C Virus – Pediatric and Adult Perspectives in the Current Decade. Pathogens 2025, 14(1), 11. https://doi.org/10.3390/pathogens14010011European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2005; 4 (1): 45–51.European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2005; 4 (1): 45–51.Ko SC, Fan L, Smith EA, et al. Estimated Annual Perinatal Hepatitis B Virus Infections in the United States, 2000–2009. Journal of the Pediatric Infectious Diseases Society. 2016; 5 (2): 114–121. doi: 10.1093/jpids/piu115.Ko SC, Fan L, Smith EA, et al. Estimated Annual Perinatal Hepatitis B Virus Infections in the United States, 2000–2009. Journal of the Pediatric Infectious Diseases Society. 2016; 5 (2): 114–121. doi: 10.1093/jpids/piu115.Ghamar Chehreh M.E., Tabatabaei S.V., Kanehara S., Alavian SM. Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIVmothers: a meta-analysis. Arch. Gynecol Obstet. 2011; 283 (2): 255–260.Ghamar Chehreh M.E., Tabatabaei S.V., Kanehara S., Alavian SM. Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIVmothers: a meta-analysis. Arch. Gynecol Obstet. 2011; 283 (2): 255–260.Indolfi G., Azzari C., Resti M. Perinatal Transmission of Hepatitis C Virus. J. Pediatr. 2013; 163 (6): 1549–1552.Indolfi G., Azzari C., Resti M. Perinatal Transmission of Hepatitis C Virus. J. Pediatr. 2013; 163 (6): 1549–1552. 51.European Paediatric Hepatitis C Virus Network. A significant sex, but not elective cesarean section-effect on mother-to-child transmission of hepatitis C virus infection. The Journal of Infectious Diseases. 2005; 11 (192): 1872–1879.European Paediatric Hepatitis C Virus Network. A significant sex, but not elective cesarean section-effect on mother-to-child transmission of hepatitis C virus infection. The Journal of Infectious Diseases. 2005; 11 (192): 1872–1879.Airoldi J, Berghella V. Hepatitis C and pregnancy. Obstetrical & Gynecological Survey. 2006; 61 (10): 666–672.Airoldi J, Berghella V. Hepatitis C and pregnancy. Obstetrical & Gynecological Survey. 2006; 61 (10): 666–672.European Association for Study of Liver/ EASL Recommendations on Treatment of Hepatitis C. Journal of Hepatology/ 2015; 63 (1):199–236.European Association for Study of Liver/ EASL Recommendations on Treatment of Hepatitis C. Journal of Hepatology/2015; 63 (1):199–236.Mohan N., et al. Clinical spectrum and natural history of chronic hepatitis C virus infection in children. Journal of Pediatric Gastroenterology and Nutrition. 2019;68(3):376– 382. DOI: 10.1097/MPG.00000000000002198.Mohan N., et al. Clinical spectrum and natural history of chronic hepatitis C virus infection in children. Journal of Pediatric Gastroenterology and Nutrition. 2019;68(3):376– 382. DOI: 10.1097/MPG.00000000000002198.Kuncio DE, Newbern EC, Johnson CC, Viner KM. Failure to Test and Identify Perinatally Infected Children Born to Hepatitis C Virus-Infected Women. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2016; 62 (8): 980–985. doi: 10.1093/cid/ciw026.Kuncio DE, Newbern EC, Johnson CC, Viner KM. Failure to Test and Identify Perinatally Infected Children Born to Hepatitis C Virus-Infected Women. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2016; 62 (8): 980–985. doi: 10.1093/cid/ciw026.Рахманова А. Г., Яковлев А. А., Кащенко В. А., Шаройко В. В. Хронический вирусный гепатит С и цирроз печени. СПб.: СпецЛит, 2016: 348.Rakhmanova A. G., Yakovlev A. A., Kashchenko V. A., et al. Chronic Viral Hepatitis C and Liver Cirrhosis. St. Petersburg: SpetsLit, 2016: 348. (In Russ.).Westbrook RH, Dusheiko G. Natural history of Нepatitis C. Journal of Hepatology. 2014; 61 (1): 58–68.Westbrook RH, Dusheiko G. Natural history of Нepatitis C. Journal of Hepatology. 2014; 61 (1): 58–68.Indolfi G., et al. Hepatitis C virus infection in children and adolescents. The Lancet Gastroenterology & Hepatology. 2019;4(6):477–487.Indolfi G., et al. Hepatitis C virus infection in children and adolescents. The Lancet Gastroenterology & Hepatology. 2019;4(6):477–487.Кистенева Л. Б., Чешик С. Г., Самохвалов Е. И. и др. Перинатальный гепатит С: комплексная оценка факторов риска. Российский Вестник Перинатологии и Педиатрии. 2012;2:58–63.Kisteneva L. B., Cheshik S. G., Samokhvalov E. I., et al. Perinatal Hepatitis C: Comprehensive Assessment of Risk Factors. Russian Bulletin of Perinatology and Pediatrics. 2012;2:58–63. (In Russ.).Rogers ME, Balistreri WF. Cascade of care for children and adolescents with chronic hepatitis C. World J Gastroenterol. 2021 Mar 28;27(12):1117–1131. doi: 10.3748/wjg.v27.i12.1117. PMID: 33828389; PMCID: PMC8006101.Rogers ME, Balistreri WF. Cascade of care for children and adolescents with chronic hepatitis C. World J Gastroenterol. 2021 Mar 28;27(12):1117–1131. doi: 10.3748/wjg.v27.i12.1117. PMID: 33828389; PMCID: PMC8006101.Гепатит С в России: нужна национальная стратегия. Доступно на: https://itpcru.org/2021/04/22/gepatit-s-v-rossii-nuzhna-naczionalnaya-strategiya/Hepatitis C in Russia: A National Strategy is Needed. Available at: https://itpcru.org/2021/04/22/gepatit-s-v-rossii-nuzhna-naczionalnaya-strategiya/WHO. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. World Health Organization, Geneva, Switzerland, 2022. Доступно на: https://iris.who.int/bitstream/handle/10665/360348/9789240053779-eng.pdf?sequence=1WHO. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. World Health Organization, Geneva, Switzerland, 2022. Available at: https://iris.who.int/bitstream/handle/10665/360348/9789240053779-eng.pdf?sequence=1WHO Global hepatitis report 2024: action for access in low- and middle-income countries. World Health Organization, Geneva, 2024. Доступно на: https://www.who.int/publications/i/item/9789240091672WHO Global hepatitis report 2024: action for access in low- and middle-income countries. World Health Organization, Geneva, 2024. Available at: https://www.who.int/publications/i/item/9789240091672

The authors declare that there are no conflicts of interest present.